In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

Objective: Ciprofloxacin resistance (CIP(R)) for Shigella isolates is becoming more prevalent. This study systematically investigated the antibacterial activity of ciprofloxacin (CIP)/fosfomycin (FOS) combination in vitro and in vivo against CIP(R) S. flexneri isolates. Method: Eighty CIP(R) S. flex...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Drug Resist
Hlavní autoři: Liu, Yanyan, Li, Hongru, Zhang, Yalong, Ye, Ying, Gao, Yufeng, Li, Jiabin
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580129/
https://ncbi.nlm.nih.gov/pubmed/31354311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S208071
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky